Christopher R Parish

发表

Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes.

Craig Freeman, C. Parish, Andrew F Ziolkowski, 2012, The Journal of clinical investigation.

Liposomal vaccines--targeting the delivery of antigen.

J. Altin, C. Parish, Christopher R Parish, 2006, Methods.

Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes

C. Parish, T. Wight, Thomas N Wight, 2014, Current Diabetes Reports.

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

Craig Freeman, Douglas Hanahan, D. Hanahan, 2005, Oncogene.

Targeting dendritic cells with antigen-containing liposomes: antitumour immunity

J. Altin, C. Parish, Christopher R Parish, 2004, Expert opinion on biological therapy.

New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes.

C. Parish, Christopher R Parish, Benjamin J C Quah, 2012, Journal of immunological methods.

DNAzyme Targeting c-jun Suppresses Skin Cancer Growth

Levon M Khachigian, Bo Wang, M. Davenport, 2012, Science Translational Medicine.

Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies.

Levon M Khachigian, L. Khachigian, C. Parish, 2006, Cardiovascular drug reviews.

Plasminogen Is Tethered with High Affinity to the Cell Surface by the Plasma Protein, Histidine-rich Glycoprotein*

J. Altin, M. Hulett, C. Parish, 2004, Journal of Biological Chemistry.

Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins*

Vito Ferro, Craig Freeman, C. Parish, 2005, Journal of Biological Chemistry.